Grants & Projects per year
Fingerprint
Dive into the research topics where Yetrib Hathout is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Characterization of a two component regulatory system in Group B Streptococcus
Cook, L. (PI), Davis, T. (CoPI), Hathout, Y. (CoPI) & Sammakia, J. (CoPI)
National Institute of Allergy & Infectious Disease
07/1/26 → 06/30/27
Project: Research
-
Biomarker Signatures for Duchenne Muscular Dystrophy
Hathout, Y. (PI)
National Inst of Neurological Disorders & Stroke
04/1/26 → 03/31/27
Project: Research
-
Pharmacodynamic biomarkers to assess muscle restorative therapies in DMD
Hathout, Y. (PI)
Foundation to Eradicate Duchenne
01/1/26 → 12/31/26
Project: Research
-
Regenxbio Research Collaboration Agreement
Nagaraju, K. (PI) & Hathout, Y. (CoPI)
01/2/23 → 12/31/26
Project: Research
-
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children
Mummidivarpu, S., Dang, U. J., Ziemba, M., Hathout, Y., Clemens, P. R., Damsker, J., Hagerty, L., Jusko, W. J., Smith, E. C., Mah, J. K., Guglieri, M., Nevo, Y., Kuntz, N., McDonald, C. M., Ryan, M. M., Castro, D., Finkel, R. S., Conklin, L. S., McCall, J. M. & Nagaraju, K. & 2 others, , Jan 2026, In: Steroids. 225, 109721.University at Buffalo, Binghamton University
Research output: Contribution to journal › Article › peer-review
Open Access -
Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL-23/CD93 Pathways in Muscle
Dang, U. J., Fang, Y., Sabbatini, D., Pegoraro, E., Bello, L., Clemens, P. R., Guglieri, M., van den Anker, J., Damsker, J., Hagerty, L., Hathout, Y., Ziemba, M., Morgenroth, L., Bhattacharya, S., Nagaraju, K., Jaiswal, J. K. & Hoffman, E. P., 2026, (Accepted/In press) In: American Journal of Medical Genetics.Research output: Contribution to journal › Article › peer-review
Open Access -
Prednisone, not vamorolone, suppresses novel serum bone and cartilage biomarkers associated with growth failure in children with Duchenne muscular dystrophy
Tobin, R. A., Dang, U. J., Hagerty, L., Ward, L. M., Rooman, R., Konopka, K. H., Clemens, P. R., Guglieri, M., Damsker, J., Ziemba, M., Hathout, Y. & Hoffman, E. P., Dec 2026, In: Scientific Reports. 16, 1, 21839.Research output: Contribution to journal › Article › peer-review
Open Access -
Quantification of Dystrophin in Human Muscle Biopsies by Mass Spectrometry
Canessa, E. H. & Hathout, Y., 2026, Methods in Molecular Biology. Humana Press Inc., p. 135-150 16 p. (Methods in Molecular Biology; vol. 2975).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophy
FOR-DMD investigators of the Muscle Study Group, Dec 2026, In: Clinical Proteomics. 23, 1, 42.Research output: Contribution to journal › Article › peer-review
Open Access